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Ayurveda (Indian system of medicine) emphasises 
three major lines of treatment viz, internal 
medications  and  diet  (Antah  Parimarjana),  external 
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therapies or topical applications (Bahir Parimarjana) 
and surgical/para-surgical procedures (Shastra 
Pranidhana) (C.S.Su11/55). These treatments are used 
in various combinations to provide optimal benefit in 
diverse disease conditions. Internal medications 
receive maximum attention for research studies, 
while the same cannot be said about external 
therapies. Osteoarthritis (OA), regarded as Sandhigata 
Vata in Ayurveda is a chronic degenerative condition 
where in topical application of herbs in the form of 
paste (Kalka), powder (Churna), oil (Taila) are widely 
prescribed.
[7]
 Upanaha Churna is one such polyherbal 
formulation, referenced from Ashtanga Hridaya, 
commonly prescribed for topical application in 
Sandhigata Vata.
[12]
 It consists of herbs Acorus 
calamus Linn. (Vacha), Anethum sowa Roxb. 
A B S T R A C T  
Background: Topical application of herbs is one of the recommended treatment modalities for 
Osteoarthritis (OA) in Ayurveda (Indian system of medicine). The current study intended to evaluate 
the anti-inflammatory effect of a polyherbal powder used as Upanaha (poultice) for OA by in vitro and 
in vivo techniques. Materials and Methods: The polyherbal formulation Upanaha Choornam (UC) 
was sourced from Vaidyaratnam Oushadhasala (P) Ltd., Thrissur, India. Changes in the secretion of 
TNF-α and NO and expression of Cox-2 genes were evaluated by semi quantitative PCR activity to 
establish anti-inflammatory action in vitro. Macrophages and connective tissue of mice were used as 
media for the former two experiments and only macrophages for the latter. In vivo anti–inflammatory 
activity was evaluated by TPA induced ear oedema in Swiss Albino mice (n=24), divided into 4 groups 
as Group I - saline treatment, Group II - Indomethacin treatment, and Groups III and IV treated with 
30% and 60% of UC respectively. Results: In the in vitro study, UC at 1000 µg/ml and 500 µg/ml 
upregulated the COX-2 level by 0.08 and 0.03 folds respectively as compared to control. Release of 
TNF-α, and NO in LPS-induced RAW cells were significantly inhibited in a dose dependent manner. The 
TPA induced ear oedema significantly reduced in Groups III and IV (F=1250, p<0.001) Conclusion: 
The current study demonstrates the safety and anti-inflammatory activity of a polyherbal formulation 
Upanaha Choornam as a topical application. This indicates the potential of select herbs in managing 
degenerative conditions like OA. 
Key words: Osteoarthritis, Upanaha, Sandhigata Vata, Poultice, Anti-Inflammatory Activity. 
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(Shatahwa), Cedrus deodara Roxb. Ex.lamb 
(Devadaru), Pluchea lanceolata DC Heirn /Alpania 
galangal Lance. (Rasna), Ricinus communis Linn. 
(Eranda), Nardostachys jatamansi DC Heirn (Jata), 
Rock salt (Saindhava Lavana), grains like Sesamum 
indica Linn. (tila), Brassica campestris Linn. 
(Sarshapa), Dolichus biflorus Linn. (Kulattha), 
Phaseolus mungo Linn. (Mudga), Phaseolus vulgaris 
Linn. (Masha), Oryza sativa Linn. (Shashtika), Panicum 
sumatrense Roth ex Roem. & Schult. (Shyamaka), 
Aquillaria agallocha Roxh (Agaru), Santalum alba Linn. 
(Hima), Coleus vettiveroides KC Jacob. (Ambu), 
Sausserria lappa CB Cl (Gada), Vettiveria zizinoides 
Linn. (Usheera). The powder is usually mixed in hot 
water and applied over the joint region as a poultice.  
Mechanical wear and tear is no longer considered the 
only cause of OA. Inflammation is an integral part of 
the disease process as seen necessitating the use of 
non-steroidal anti-inflammatory drugs (NSAIDs) 
frequently to manage the symptoms.
[4-5]
 Inflammation 
promotes synovitis and also enhances cartilage and 
bone destruction. The innate and adaptive immune 
systems are activated and pro-inflammatory cytokines 
are released [Charles J Malemud, 2015]. Prolonged 
use of NSAIDs however can adversely affect the liver, 
kidney, gut, skin and cardiovascular system and 
hence, has to be prescribed with extreme caution.
[6]
 
As the disease affects the ageing population, co-
morbidities like hypertension, diabetes mellitus, 
cardiac disease etc. also prevent optimal prescription 
of oral medication. Hence safer and effective topical 
applications need to be explored as alternatives. 
Though there are few studies that have explored the 
potential of Ayurveda interventions in OA, most of 
them are restricted to evaluating the effect of oral 
medication. Herbs like Tribulus terrestris Linn. 
(Gokshura), Tinospora cordifolia Hook F & Thoms. 
(Guduchi), Zingiber officinale Rosc. (Shunti), Emblica 
officinalis Gaertn. (Amalaki), Boswellia serrata Roxh. 
(Shallaki), Withania somnifera Linn. (Ashwagandha) 
have been demonstrated to be safe and effective in 
ameliorating OA symptoms. These herbs have shown 




A cursory review of topical herbal therapies for OA 
details Arnica gel, capsicum extract gel, comfrey 
extract gel and an adhesive patch of Chinese herbal 
mixture.
[13]
 An in vitro study of oral and topical 
application of boswellic acid showed reduction in 
cartilage loss, synovitis and osteophyte formation.
[14]
 
Though topical applications are greatly used in 
Ayurveda for the management of OA, minimal data is 
currently available to demonstrate its effectiveness 
and also indicating the molecular and cellular 
mechanisms of their action. With this background, the 
anti-inflammatory effect of Upanaha Choornam (UC) 
was tested in mice induced with inflammation along 
with evaluating its activity on the expression of 
inflammatory markers.  
MATERIALS AND METHODS 
The polyherbal formulation UC was sourced from 
Vaidyaratnam Oushadhasala (P) Ltd., Thrissur, India, 
Batch no. 3843, manufactured in March 2015. The in-
vitro and in-vivo study was conducted at Radiant 
Research Services Pvt. Ltd, Bangalore, India, following 
their Standard Operating Procedure.  
In-vitro studies 
The test systems used for in vitro evaluation were 
RAW 264.7 (macrophages of mouse) and L929 
(connective tissue of mouse). The test product UC was 
stored under normal room temperature, coded as 
RR2706 in the records. 
Preparation of Test Doses 
For studies, each weighed UC were separately 
dissolved in distilled Dimethyl sulfoxide (DMSO) and 
volume was made up with Dulbecco's Modified Eagle 
Medium (DMEM) supplemented with 2% inactivated 
Fetal Bovine solution (FBS) to obtain a stock solution 
of 1 mg/ml concentration and sterilized by filtration. 
Serial two fold dilutions were prepared from this for 
carrying out cytotoxic studies. 
Determination of Cytotoxicity in Raw and L929 cell 
lines
[15] 
The monolayer cell culture was trypsinized and the 
cell count was adjusted to 1.0 x 10
5 
cells/ml using 
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DMEM containing 10% FBS. To each well of the 96 
well microtitre plate, 0.1 ml of the diluted cell 
suspension (approximately 10,000 cells) was added. 
After 24 h, when a partial monolayer was formed, the 
supernatant was flicked off, washed the monolayer 
once with medium and 100 µl of different test 
concentrations of UC was added on to the partial 
monolayer in microtitre plates. The plates were then 
incubated at 37
o 
C in 5% CO2 atmosphere. After 24 h, 
the drug solutions in the wells were discarded and 50 
µl of MTT in PBS was added to each well. The plates 
were gently shaken and incubated for 3 h at 37
o 
C in 
5% CO2 atmosphere. The supernatant was removed 
and 100 µl of propanol was added and the plates 
were gently shaken to solubilize the formed formazan. 
The absorbance was measured using a microplate 
reader at a wavelength of 540 nm. The percentage 
growth inhibition was calculated and concentration of 
UC needed to inhibit cell growth by 50% (CTC50) values 
is generated from the dose-response curves for each 
cell line. 
In vitro TNF-α inhibitory activity of extracts
[16] 
Step I: Induction of TNF-α in RAW cells: RAW cells 
seeded in to 6 well culture dishes at a cell population 
1.5 to 2x10
5
 cells/ml in DMEM with 10% FBS. After 24 
h, the cells were treated with known non-toxic 
concentration of test extracts along with 1µg/ml of 
lipopolysaccharide (LPS) and incubated at 37
0
C with 
5% CO2 for 4 h. After incubation, the cell supernatant 
was collected, centrifuged, separated and stored at -
20
0
 C till use.  
Step II: Estimation of TNF-α in cell supernatant by 
bioassay: L929 monolayer cell culture was trypsinized 
and the cell count was adjusted to 1.0 x 10
5 
cells/ml 
using MEM medium containing 10% FBS. To each well 
of the 96 well microtitre plate, 0.1 ml of the diluted 
cell suspension (approximately 10,000 cells) was 
added. After 24 h, when a partial monolayer was 
formed, the supernatant was flicked off, washed the 
monolayer once with medium and 100 µl of diluted 
samples from the step I were added to the cells in 
quadruplicate wells. The cultures were then incubated 
at 37°C for 24 h in 5% CO2 atmosphere. After 24h, the 
drug solutions in the wells were discarded and 50 µl 
of MTT in PBS was added to each well. The plates 
were gently shaken and incubated for 3 h at 37°C in 
5% CO2 atmosphere. The supernatant was removed 
and 100 µl of propanol was added and the plates 
were gently shaken to solubilise the formed formazan. 
The absorbance was measured using a microplate 
reader at a wavelength of 540 nm and the percentage 
cell viability was calculated. The cell viability is direct 
indication of inhibitory properties of extracts against 
LPS induced TNF production in RAW cells.  
Nitrite determination (Nitric oxide inhibition): RAW 
cells were treated with LPS and test samples as 
described above and incubated for 24 h and 
conditioned media collected were used for nitrite 
determination. Determination of nitrite as a 
biomarker for NO was carried out. In brief, equal 
volume (50 μL) of 0.1% N-1-napthylethylenediamine 
dihydrochloride prepared in water, 1% sulfanilamide 
prepared in 5% phosphoric acid and cell culture media 
were mixed in flat bottom 96-well plate incubated for 
10–15 min. Colored end product was measured at 530 
nm. Percentage of nitric oxide inhibition was 
calculated over LPS control 
RT-PCR Procedure: The mRNA expression levels of 
COX 2 carried out using semi-quantitative reverse 
transcriptase-polymerase chain reaction (RT-PCR). 
Briefly, the RAW cells were cultured in 60 mm 
petridish and maintained in DMEM medium for 48 
hrs. The DMEM medium was supplemented with FBS 
and Amphotericin. To the dish was added the 
required concentration of Test sample (1000 and 500 
µg/ml) and incubated for 24 hr. Total cellular RNA was 
isolated from the untreated (control) and treated cells 
using Tri Reagent according to manufacturer’s 
protocol. cDNA was synthesized from total isolated 
RNA by reverse transcriptase kit according to 
manufacturer’s instructions. Then 50μl of the reaction 
mixture was subjected to PCR for amplification of COX 
2 cDNAs using specifically designed primers procured 
from Eurofins India, as an internal control, the house 
keeping gene GAPDH was co-amplified with each 
reaction. 
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In vivo study 
The in vivo study was performed in Swiss Albino mice 
(n=24) of either gender, by TPA induced ear oedema. 
The study was approved by committee for the 
purpose of control and supervision of experiments on 
animals (CPCSEA) and Institutional Animal Ethics 
Committee (IAEC) with registration number 
1803/PO/RcBiS/2015/CPCSEA.  
The mice were randomly grouped into 4 groups with 6 
mice in each, weighing 25 to 30 g. accommodated in 
standard polycarbonate cages under standard 
laboratory conditions. The animals were acclimatised 
using laboratory conditions for 5 days, 7 days and 9 
days respectively for step I, step II and step III 
respectively after veterinary examination. Only the 
animals without any physical signs of illness were 
selected. The mode of application of the UC was 
topical. The animals were allocated as: Group I was 
Control group received normal saline only, Group II 
was treatment group treated with STD (Indomethacin 
0.5mg), Group III was Treatment group treated with 
UC (30% of UC) and Group IV was treatment group 
treated with UC (60% of UC). Thirty percent is 1ml 
Tween 80 + 300mg UC, sixty percent is 1ml Tween 80 
+ 600mg UC (Tween 80 was procured from Central 
Drug House, Bangalore).  
The left ear was considered as contra lateral control 
and received only saline solution. Inflammation was 
induced to the ear of mice by applying TPA (12-O-
tetradecanoyl-phorbol-13-acetate, procured from 
Sigma, Bangalore) (2.5 μg/ear) and Xylene (20 μL/ear) 
on the inner and outer surfaces of the right ear and 
left undisturbed for 30 mins. Application was done 
between 9.00 and 9.30 am and ear oedema was 
evaluated at 0, 30, 60, 120, 180, 240 and 300 mins 
after TPA application. After 5 hours of the treatment, 
mice were subjected to CO2 euthanasia and sacrificed 
by cervical dislocation and each ear (8mm diameter) 
biopsies was done and weighed immediately. Oedema 
was measured in terms of weight difference of the 
ears and the ear thickness was measured before and 
after induction of the inflammatory response using a 
digital micrometer.  
STATISTICAL ANALYSIS 
The In vivo data are represented as Mean ± SE. 
Comparison between groups was made by One-way 
ANOVA, differences with p<0.05 were considered 
significant. 
RESULTS 
In vitro study: UC showed moderate cytotoxicity, on 
the basis of CTC50 value the concentration of the UC in 
RAW cell line. The cytotoxicity activity against the 
RAW cells and L929 cells increased with increasing 
dose (Tables 1-2). The test product showed dose 
dependent anti-inflammatory activity with moderate 
TNF-alpha inhibition, nitric oxide inhibition properties 
(Tables 3-4). In gene expression study, UC showed 
regulation on the levels of COX-2 expression. UC i.e. 
1000 µg/ml and 500 µg/ml up regulate the COX-2 
level by 0.08 fold and 0.03 as compare to control 
(Figure 1).  
In vivo study: UC decreased the TPA induced ear 
oedema during the observation period when 
compared to control group (F=1250, p<0.001) (Figure 
2). The inhibition was found to be 52.3 and 61.9 % at 
300 mins, respectively (Table 5). 
Table 1: Cytotoxic properties of UC against RAW cell 
line 












Table 2: Cytotoxic properties of UC against L929 cell 
line 
Test Conc. (%) % Cytotoxicity CTC50 (µg/ml) 
1000 43.83±1.1 >1000  
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Table 3: Anti-inflammatory effect of UC in RAW cells 
against LPS induced TNF production 




1 UC 500 µg/ml 48.2±1.9 
2 UC 250 µg/ml 25.6±1.0 
3 Dexamethasone 200 µM 67.3±1.7 
Table 4: Anti-inflammatory effect of UC in RAW cells 
against LPS induced Nitric oxide production. 
SN Concentration tested % NO inhibition 
1 500 µg/ml 14.8±0.39 
2 250 µg/ml 9.5±0.13 












































Targeting inflammation is considered as the initial 
step for effective management of Osteoarthritis. In 
the current study, the anti-inflammatory potential of 
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an Ayurveda polyherbal formulation Upanaha Churna 
(UC) used widely for topical application in Sandhigata 
Vata (OA) was evaluated. Both in vitro and in vivo 
experimental protocols were followed and significant 
effects were obtained. The study has aided 
understanding of the probable mode of action of the 
polyherbal formulation UC.  
To the best of our knowledge, there are very few 
studies that have looked into the utilitarian aspect of 
topical applications for inflammatory conditions like 
OA. The latest recommendations for OA management 
too indicate towards the positive outcomes of topical 
applications.
[18]
 The mechanism of action by which 
these provide analgesia is proposed to be similar to 
oral medications, albeit with a better safety profile.
[1]
 
Topical NSAIDs have produced fewer systemic adverse 
events and also shown effect in OA as per a Cochrane 
review.
[19]
 Though even in Ayurveda pharmacopoeia, 
topical applications are widely used for Sandhigata 
Vata (OA), there are very few studies that have delved 
into the mechanisms by which these medications 
work. Singh and colleagues reported the anti-
inflammatory activity of Boswellic acids when applied 
topically in models of acute and chronic 
inflammation.
[20]
 Another in vitro study of a 
polyherbal formulation containing Z. officinalis, T. 
cordifolia, E.officinalis and B.serrata on human knee 
cartilage has shown significant reduction of 
breakdown products glycosaminoglycan and 
aggrecan.
[21]
 The chondroprotective effect and 
regenerative ability of Cissus quandrangularis Linn. 
(Asthishrinkala) has also been demonstrated in 
human chondrocytes. The effect is attributed to the 
inhibition of the p38MAPK signalling pathway by the 
upregulation of survivin.
[22]
 A polyherbal compound 
BV-9238 containing W. somnifera, B. serrata, Z. 
officinale and C. longa inhibited TNF-α and nitric oxide 
(NO) production in RAW cell lines.
[23]
 Curcumin, by 
virtue of itsanti-apoptotic and anti-catabolic effects 
on IL-1beta-stimulated articular chondrocytes, is also 
considered as a potent remedy in OA.
[24]




In clinical settings too, herbal topical applications have 
shown reduction in pain and stiffness, and 
improvement in mobility. A cream containing 
Trigonella foenum-graceum Linn. (fenugreek), 
Curcuma longa Linn. (turmeric), coconut oil, castor oil, 
capsaicin, Mentha sylvestris Linn. (menthol) and other 
ingredients reduced pain and stiffness in hand and 
knee OA. The activity of the cream though decayed at 
onset, sustained for longer duration when compared 
with other topical applications.
[26]
 A meta-analyses of 
topical herbal applications reported that trials of 
boswellia and curcumin mixture and B.serrata alone, 
reduced pain and improved movement.
[27]
 Another 
herbal ointment containing Cinnamomum verum 
Presl. (cinnamon), G. officinalis, saghez (resin of tree 
Pistacia lentiscus) and sesame oil decreased pain, 
morning stiffness and limited motion in patients of 
knee OA; its effect were comparable with Salicylate 
ointment.
[28]
 Topical ginger (Z. officinalis) compress 
and pack reduced pain and fatigue and improved 
functionality and satisfaction in OA patients.
[29]
 Herbal 
compounds are hypothesized to modulate several 
inflammation triggering factors, pathway mediators 




In the current study, Upanaha Choornam showed a 
significant anti-inflammatory activity, comparable to 
that of standard analgesic Indomethacin. Increased 
concentration did not seem to offer better benefit. 
The in-vitro studies helped to understand the 
mechanism of action of the polyherbal formulation. 
The role of inflammatory cytokines in the 
pathogenesis of OA is seemingly very clear. TNF-α and 
IL-1β are prominently involved, the former driving the 
inflammatory process and the latter contributing to 
cartilage destruction.
[31]
 Cartilage breakdown is also 
promoted by NO, though its beneficial effects are also 
proposed.
[32]
 Increase in COX-2 levels is also observed 
in inflammation, leading to efforts to curb its 
expression.
[33]
 It is also proposed that anti-cytokine 
therapy may be a potential Disease-modifying OA 
drugs.
[34-36]
 UC too inhibited TNF-α and NO and COX-2 
expression and hence we may infer that it has the 
potential to reduce destruction in OA. 
Herbs have been used since times immemorial for 
their medicinal properties, especially in India which 
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has its own indigenous healthcare system Ayurveda. 
We have here reported the anti-inflammatory activity 
of an Ayurveda polyherbal formulation Upanaha 
Choornam, used as a topical application in 
Osteoarthritis. This may have implications in better 
management of this degenerative condition.  
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